Unknown

Dataset Information

0

Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment.

ABSTRACT:

SUBMITTER: Hinge M 

PROVIDER: S-EPMC5046665 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment.

Hinge Maja M   Andersen Kristian T KT   Lund Thomas T   Jørgensen Henrik B HB   Holdgaard Paw C PC   Ormstrup Tina E TE   Østergaard Lone L LL   Plesner Torben T  

Haematologica 20160630 10

Similar Datasets

Unknown Effects of Exercise Training on the Bone Marrow Immune Microenvironment and Minimal Residual Disease in Multiple Myeloma Patients Following First-Line Treatment.
| S-EPMC11760657 | biostudies-literature
Unknown Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition.
| S-EPMC12372396 | biostudies-literature
Unknown Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.
| S-EPMC11607340 | biostudies-literature
Unknown A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients.
| S-EPMC3031705 | biostudies-literature
Unknown Pathogenic germ line variants in a prospective multicenter cohort of patients with multiple myeloma.
| S-EPMC12182856 | biostudies-literature
Unknown Design, synthesis, and biological evaluation of bone-targeted proteasome inhibitors for multiple myeloma.
| S-EPMC3836429 | biostudies-literature
Unknown Bone Pain in Multiple Myeloma (BPMM)-A Protocol for a Prospective, Longitudinal, Observational Study.
| S-EPMC8036720 | biostudies-literature
Unknown Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained response.
| S-EPMC5806105 | biostudies-literature
Unknown First-line anti-BCMA CAR-T cell therapy in a fragile patient with biclonal gammopathy and giant plasma cell tumor multiple myeloma with multiple comorbidities: a case report.
| S-EPMC12040831 | biostudies-literature
Unknown First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro.
| S-EPMC2970902 | biostudies-literature